|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2003-11-24
|
|
pubmed:abstractText |
The distinction of metastatic breast adenocarcinoma (MBA) to the liver from hepatocellular carcinoma (HCC), cholangiocarcinoma (CC), and metastatic adenocarcinoma from other sites may require the use of immunohistochemistry. The use of antibodies directed against estrogen receptor (ER) and progesterone receptor (PR) has been suggested to help make this distinction.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1543-2165
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
127
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1591-5
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:14632573-Adenocarcinoma,
pubmed-meshheading:14632573-Biological Markers,
pubmed-meshheading:14632573-Breast Neoplasms,
pubmed-meshheading:14632573-Carcinoma,
pubmed-meshheading:14632573-Carcinoma, Hepatocellular,
pubmed-meshheading:14632573-Diagnosis, Differential,
pubmed-meshheading:14632573-Female,
pubmed-meshheading:14632573-Humans,
pubmed-meshheading:14632573-Immunohistochemistry,
pubmed-meshheading:14632573-Liver Neoplasms,
pubmed-meshheading:14632573-Receptors, Estrogen,
pubmed-meshheading:14632573-Receptors, Progesterone
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
The utility of estrogen receptor and progesterone receptor immunohistochemistry in the distinction of metastatic breast carcinoma from other tumors in the liver.
|
|
pubmed:affiliation |
Department of Pathology, The Ohio State University, Columbus, USA.
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
